In vivo confocal microscopy of patients with amiodarone-induced keratopathy

被引:45
作者
Ciancaglini, M [1 ]
Carpineto, P [1 ]
Zuppardi, E [1 ]
Nubile, M [1 ]
Doronzo, E [1 ]
Mastropasqua, L [1 ]
机构
[1] Univ G dAnnunzio, Inst Ophthalmol & Legal Med, Chieti, Italy
关键词
amiodarone; confocal microscopy; keratopathy;
D O I
10.1097/00003226-200105000-00007
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose, To describe the corneal findings in patients with amiodarone-induced keratopathy by means of in vivo confocal microscopy, Methods. Twenty-two eves of 11 patients (eight men and three women) receiving amiodarone therapy and 20 eyes of 10 healthy sex- and age-matched control subjects were selected for confocal microscopic examination. The patients were examined by use of a scanning slit corneal confocal microscope (Confoscan 2.0). Five complete scans of the entire cornea were performed for each eye with a total examination time of less than 5 minutes. Results. All patients receiving amiodarone showed the presence of high reflective, bright intracellular inclusions in the epithelial layers. These findings were more evident within the basal cell layers. In the eyes with advanced keratopathy (stages 2 and 3). bright microdots were detectable within the anterior and posterior stroma and on the endothelial cell laver. In the anterior stroma. the keratocyte density in the treated group was reduced compared with values of the control group (p < 0.001), and a markedly irregular aspect of the stromal nel ve fibers was found. The main characteristic of this nerve irregularity was represented by the clew-shaped appearance of the nerve trunks. Conclusion. Detailed examination of corneal structure by confocal microscopy shows that amiodarone keratopathy in long-term treated patients presents some findings that are consistent with higher toxicity than was expected and that involve the deep central layers.
引用
收藏
页码:368 / 373
页数:6
相关论文
共 24 条
[1]  
CAVANAGH HD, 1993, OPHTHALMOLOGY, V100, P1444
[2]  
CHATELAIN P, 1985, RES COMMUN CHEM PATH, V50, P407
[3]   AMIODARONE KERATOPATHY - DRUG-INDUCED LIPID STORAGE DISEASE [J].
DAMICO, DJ ;
KENYON, KR ;
RUSKIN, JN .
ARCHIVES OF OPHTHALMOLOGY, 1981, 99 (02) :257-261
[4]  
Davitt SP, 1997, CORNEA, V16, P695
[5]  
Dolan BJ, 1985, J AM OPTOM ASSOC, V54, P468
[6]  
Francois J, 1968, Bull Soc Belge Ophtalmol, V150, P656
[7]  
GHOSH M, 1984, CAN J OPHTHALMOL, V19, P178
[8]   TOXIC AND THERAPEUTIC EFFECTS OF AMIODARONE IN THE TREATMENT OF CARDIAC-ARRHYTHMIAS [J].
GREENE, HL ;
GRAHAM, EL ;
WERNER, JA ;
SEARS, GK ;
GROSS, BW ;
GORHAM, JP ;
KUDENCHUK, PJ ;
TROBAUGH, GB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1983, 2 (06) :1114-1128
[9]   SIDE-EFFECTS AND POSSIBLE CONTRAINDICATIONS OF AMIODARONE USE [J].
HARRIS, L ;
MCKENNA, WJ ;
ROWLAND, E ;
KRIKLER, DM .
AMERICAN HEART JOURNAL, 1983, 106 (04) :916-923
[10]   ROLE OF PHOSPHOLIPASE-A INHIBITION IN AMIODARONE PULMONARY TOXICITY IN RATS [J].
HOSTETLER, KY ;
REASOR, MJ ;
WALKER, ER ;
YAZAKI, PJ ;
FRAZEE, BW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 875 (02) :400-405